Shaping a new-born business
 
We were very involved from the very start – devising the company name and then helping the leaders define and roll-out their corporate positioning. Having secured the biggest private fundraising of 2008 in Switzerland, the company has just released positive Phase 2a data for its potential treatment for Parkinson’s disease and negotiated a second deal with Roche. We’ve helped Synosia keep up with their achievements, ensuring their success is recognised by the industry press and award makers.

Go back >>